Telix Completes Acquisition of Atlab for Prostate Cancer Program

Go back to Telix Completes Acquisition of Atlab for Prostate Cancer Program
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.09 +0.15 (1.51%)
Previous Close $9.94    52 Week High $2.18 
Open $10.01    52 Week Low $0.30 
Day High $10.16    P/E N/A 
Day Low $9.95    EPS $-3.32 
Volume 90,462